Industry & Business

Takeda to Invest €25 Million at Grange Castle Site in Dublin

 Breaking News
  • EIB to Back €1.2 Billion Pan-European Renewable Investment Through Irish NTR Fund The world’s largest international financier for renewable energy, the European Investment Bank, will back renewable energy investment across Europe in co-operation with Dublin-based NTR plc. The EIB’s €84 million backing for the NTR Renewable Energy Income Fund II was announced at an EIB investment conference at the Central Bank of Ireland attended by more than [...]...
  • ABP’s Olleco on Shortlist For Davos Sustainability Award ABP Food Group’s renewable division, Olleco, has been shortlisted for a prestigious ‘Circular’ sustainability award for its development of a circular economy model with McDonald’s and Arla Foods in the UK. The awards are an initiative of the World Economic Forum and the Forum of Young Global Leaders and winners will be announced at the [...]...
  • Pioneering Proteomics Researcher and Entrepreneur Receives the NovaUCD 2018 Innovation Award The NovaUCD 2018 Innovation Award has been presented to University College Dublin’s (UCD) Professor Stephen Pennington (pictured), a global leader in proteomics (the study of proteins) research and innovation. The Award was presented to him in recognition of his commitment and success in protein biomarker research, undertaken during the last 15-years at the UCD School [...]...
  • National Manufacturing & Supply Chain Conference & Exhibition 2019 – Thursday, January 17th – Citywest Hotel, Dublin Approximately 3,000 people from all over Ireland are expected to visit the 2019 National Manufacturing & Supply Chain Conference & Exhibition at the Citywest Hotel, Dublin on Thursday, January 17th, making the event the largest gathering of the manufacturing and supply chain community in the country. Now in its sixth year, the National Manufacturing and Supply [...]...
  • DIT Launches New MSc in Transport and Mobility Over 250 million journeys were taken by passengers on Irish public transport services in 2017, and with the population set to increase, this number is likely to continue growing in the coming years. Dublin Institute of Technology (DIT) has launched Ireland’s first ever MSc programme in Transport and Mobility designed to equip graduates with the knowledge [...]...

Takeda to Invest €25 Million at Grange Castle Site in Dublin

Takeda to Invest €25 Million at Grange Castle Site in Dublin
March 05
11:57 2018

Takeda Pharmaceutical Company is to create up to 70 new jobs and invest €25 million in the construction of a new regenerative medicine facility at its site in Grange Castle. The investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy. The investment will also create 70 temporary construction jobs.

The facility will be in commercial operation by 2021. This investment is supported by the Irish Government through IDA Ireland.

The largest pharmaceutical company in Japan, Takeda first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002 Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan. In 2017 Takeda also announced a €40 million investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio at Grange Castle.

Welcoming the announcement Pat Breen TD, Minister of State at the Department of Enterprise and Innovation, said: “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest growing sectors. Takeda’s decision to invest in Ireland is a great win and vote of confidence in Ireland and it builds on our ongoing expansion of the sector here. I’m delighted that this investment will bring a further 70 jobs to the company’s existing Clondalkin facility.”

Paul Keogh, Plant Director at Takeda Ireland Grange Castle, said that the additional investment in Ireland demonstrates the confidence and commitment Takeda has in its Irish operation. “To be chosen as the first site to introduce this new technology platform to our manufacturing network is very exciting. The nature of this product and its process will bring us closer to the patient than ever before which is a responsibility that we take very seriously. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site. The roles being created are in the areas of quality, manufacturing and engineering.”

Martin Shanahan, CEO of IDA Ireland, said: “Ireland is a globally recognised centre of excellence in Life sciences due to the country’s strong regulatory track record and talent availability. The investment by Takeda demonstrates their continued commitment to Ireland.”

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4